SBC
SBC Medical Group Holdings
PE ratio, current and historical analysis
- Stocks
- Industrials
- NASDAQ: SBC
- PE Ratio
The price-to-earnings ratio for SBC Medical Group Holdings stock stands at 7.85 as of Jul 31, 2026. This results from the current EPS of $0.39 and stock price of $3.06. A decrease of 29% has been recorded in the P/E ratio compared to the average of 11.1 of the last 4 quarters.
SBC PE ratio history
Over the last four years, the average PE ratio of SBC Medical Group Holdings has been 18.63. The current 7.85 PE ratio is 58% below the historical average. In the past four years, SBC's PE ratio was at its highest in the Mar 2023 quarter at 104.4, with a price of $10.44 and an EPS of $0.1. The Mar 2025 quarter recorded the bottom point at 6.38, with a price of $3.19 and an EPS of $0.5.
SBC Medical Group Holdings PE ratio by year
Maximum annual increase: 98.61% in 2023
Maximum annual decrease: -54.84% in 2024
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 8.62 | -25.56% | $4.31 | $0.5 |
| 2024 | 11.58 | -54.84% | $5.56 | $0.48 |
| 2023 | 25.64 | 98.61% | $10.77 | $0.42 |
| 2022 | 12.91 | N/A | $10.2 | $0.79 |
SBC Medical Group Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 10.72 | 24.36% | $4.18 | $0.39 |
| Dec 2025 | 8.62 | -18.6% | $4.31 | $0.5 |
| Sep 2025 | 10.59 | -26.97% | $4.34 | $0.41 |
| Jun 2025 | 14.5 | 127.27% | $4.64 | $0.32 |
| Mar 2025 | 6.38 | -44.91% | $3.19 | $0.5 |
| Dec 2024 | 11.58 | -15.72% | $5.56 | $0.48 |
| Sep 2024 | 13.74 | -32.71% | $7.97 | $0.58 |
| Jun 2024 | 20.42 | 186.4% | $13.07 | $0.64 |
| Mar 2024 | 7.13 | -72.19% | $12.7 | $1.78 |
| Dec 2023 | 25.64 | 267.34% | $10.77 | $0.42 |
| Sep 2023 | 6.98 | -2.38% | $10.68 | $1.53 |
| Jun 2023 | 7.15 | -93.15% | $10.29 | $1.44 |
| Mar 2023 | 104.4 | 708.68% | $10.44 | $0.1 |
| Dec 2022 | 12.91 | N/A | $10.2 | $0.79 |
| Sep 2022 | N/A | N/A | $10.02 | N/A |
SBC Price vs fair value
SBC average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PE comparison
With a P/E of 7.85, SBC stands below the Industrials sector and the industry average. Compared to its Industrials sector average of 28.25, SBC Medical Group Holdings's P/E is 72% lower.
Frequently asked questions
What is SBC Medical Group Holdings's PE ratio?
The price to earnings ratio for SBC stock as of Jul 31, 2026, stands at 7.85.
What is the highest PE ratio for SBC?
The highest quarterly PE ratio in the last four years has been 104.4 and it was in the Mar 2023 quarter.
How does the current PE ratio for SBC compare to its historical average?
SBC's price to earnings ratio is currently 58% below its 4-year historical average.
Why is SBC Medical Group Holdings's PE ratio so low?
SBC's PE ratio is low because the stock price is relatively cheap compared to the earnings generated by the company.
How is SBC's PE ratio calculated (SBC Medical Group Holdings PE ratio formula)?
The PE ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Jul 31, 2026), SBC Medical Group Holdings's stock price is $3.06. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $0.39. Therefore, SBC Medical Group Holdings's P/E ratio for today is 7.85. PE RATIO(7.85) = STOCK PRICE($3.06) / TTM EPS($0.39)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.